233 related articles for article (PubMed ID: 31229797)
1. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
[TBL] [Abstract][Full Text] [Related]
3. Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies.
El-Shoukrofy MS; Abd El Razik HA; AboulWafa OM; Bayad AE; El-Ashmawy IM
Bioorg Chem; 2019 Apr; 85():541-557. PubMed ID: 30807897
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential.
Said MF; Georgey HH; Mohammed ER
Eur J Med Chem; 2021 Nov; 224():113682. PubMed ID: 34245948
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds.
Atatreh N; Youssef AM; Ghattas MA; Al Sorkhy M; Alrawashdeh S; Al-Harbi KB; El-Ashmawy IM; Almundarij TI; Abdelghani AA; Abd-El-Aziz AS
Bioorg Chem; 2019 May; 86():393-400. PubMed ID: 30763886
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis of celecoxib-tolmetin drug hybrids as selective and potent COX-2 inhibitors.
Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
Bioorg Chem; 2019 Sep; 90():103029. PubMed ID: 31212177
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel pyrazole derivatives as anti-inflammatory antimicrobial agents.
Bekhit AA; Ashour HM; Bekhit Ael-D; Bekhit SA
Med Chem; 2009 Mar; 5(2):103-17. PubMed ID: 19275709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors.
Mroueh M; Faour WH; Shebaby WN; Daher CF; Ibrahim TM; Ragab HM
Bioorg Chem; 2020 Jul; 100():103895. PubMed ID: 32413626
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and docking study of N-(2-(3,4,5-trimethoxybenzyl)benzoxazole-5-yl) benzamide derivatives as selective COX-2 inhibitor and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Narasimhan B; Sharma P; Mathur R; Wakode S
Bioorg Chem; 2018 Dec; 81():191-202. PubMed ID: 30138907
[TBL] [Abstract][Full Text] [Related]
15. New substituted pyrazole derivatives targeting COXs as potential safe anti-inflammatory agents.
Abdellatif KR; El-Saadi MT; Elzayat SG; Amin NH
Future Med Chem; 2019 Aug; 11(15):1871-1882. PubMed ID: 31517535
[No Abstract] [Full Text] [Related]
16. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS
Bioorg Chem; 2016 Feb; 64():1-12. PubMed ID: 26561742
[TBL] [Abstract][Full Text] [Related]
17. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
[TBL] [Abstract][Full Text] [Related]
18. Screening of curcumin-derived isoxazole, pyrazoles, and pyrimidines for their anti-inflammatory, antinociceptive, and cyclooxygenase-2 inhibition.
Ahmed M; Qadir MA; Hameed A; Imran M; Muddassar M
Chem Biol Drug Des; 2018 Jan; 91(1):338-343. PubMed ID: 28741789
[TBL] [Abstract][Full Text] [Related]
19. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
20. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]